[1]韩洁玢,孙淮庆,王佩佩,等.地中海饮食通过调控肝脏X受体改善阿尔茨海默病小鼠认知功能[J].陕西医学杂志,2025,54(7):873-881,893.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.002]
 HAN Jiebin,SUN Huaiqing,WANG Peipei,et al.The Mediterranean diet improves cognitive function in Alzheimer’s disease mice by regulating liver X receptors[J].,2025,54(7):873-881,893.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.002]
点击复制

地中海饮食通过调控肝脏X受体改善阿尔茨海默病小鼠认知功能

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年7期
页码:
873-881,893
栏目:
基础研究
出版日期:
2025-07-05

文章信息/Info

Title:
The Mediterranean diet improves cognitive function in Alzheimer’s disease mice by regulating liver X receptors
作者:
韩洁玢1孙淮庆2王佩佩1董粤蓉1吴婷2何清1
(1.徐州医科大学附属徐州市立医院,江苏 徐州 221000;2.南京医科大学南京第一附属医院,江苏 南京 210029)
Author(s):
HAN Jiebin1SUN Huaiqing2WANG Peipei1DONG Yuerong1WU Ting2HE Qing1
(1.Department of Neurology,The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University,Xuzhou 221000,China;2.Department of Neurology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)
关键词:
地中海饮食阿尔茨海默病认知功能障碍肝脏X受体神经炎症5xFAD小鼠
Keywords:
Mediterranean dietAlzheimer’s diseaseCognitive dysfunctionLiver X receptorsNeuroinflammation5xFAD mice
分类号:
R 742
DOI:
DOI:10.3969/j.issn.1000-7377.2025.07.002
文献标志码:
A
摘要:
目的:探讨地中海饮食(MD)对小鼠认知功能、突触功能、神经炎症及Aβ沉积的改善作用及其潜在机制。方法:C57BL/6小鼠10只作为对照组,5xFAD小鼠20只随机分为5xFAD组和5xFAD-MD组,每组各10只,对5xFAD-MD组小鼠进行8周MD干预,对照组和5xFAD组小鼠每天给予普通饲料饲养。通过Y迷宫、新物体识别和巴恩斯迷宫测试评估小鼠认知功能,采用免疫印迹检测突触相关蛋白突触后致密蛋白95(PSD95)和突触蛋白1(SYN-1)表达量,利用硫磺素-S染色、免疫荧光及免疫印迹评估海马Aβ沉积水平,免疫荧光检测海马小胶质细胞肝脏X受体(LXR)的激活情况。结果:与对照组比较,5xFAD小鼠体型小、毛发毛躁稀疏,体重增长下降;进入新异臂的时间百分比、进入新异臂的次数及新物体识别测试阶段接触新换物体侧的时间百分比显著下降(均P<0.05)、测试期小鼠找到迷宫目标区域时间延长(P<0.05),Aβ蛋白表达水平、小胶质细胞数量显著增加(均P<0.05),小鼠脑内LXR荧光强度降低,PSD95、SYN-1的表达减少(均P<0.05);与5xFAD组比较,5xFAD-MD组小鼠体型大、毛发浓密、体重增长,进入新异臂的时间百分比、新物体识别测试阶段接触新换物体侧的时间百分比增加(均P<0.05)、测试期小鼠找到迷宫目标区域时间缩短(P<0.05),Aβ蛋白表达水平、小胶质细胞数量显著下降(均P<0.05),小鼠脑内LXR荧光强度增加,PSD95、SYN-1的表达增加(均P<0.05)。结论:MD通过改善突触功能和抑制神经炎症,发挥对5xFAD小鼠的认知保护作用,其机制可能与激活LXR并抑制小胶质细胞活化有关。
Abstract:
Objective:This study aimed to investigate the effects of the Mediterranean Diet(MD) on cognitive function,synaptic function,neuroinflammation,and Aβ deposition in 5xFAD mice,and to explore the potential underlying mechanisms.Methods:Ten C57BL/6 mice were used as the control group,and 20 5xFAD mice were randomly divided into the 5xFAD group and the 5xFAD-MD group,with 10 mice in each group.The 5xFAD-MD group mice were subjected to an 8-week MD intervention,while the control group and the 5xFAD group mice were fed normal chow daily.The cognitive function of the mice was evaluated by Y-maze,novel object recognition and Barnes maze tests.The expression levels of synaptic-related proteins PSD95 and SYN-1 were detected by Western blotting.The Aβ deposition level in the hippocampus was evaluated by Thioflavin-S staining,immunofluorescence and Western blotting.The activation of LXR receptor in hippocampal microglia was detected by immunofluorescence.Results:Compared with the control group,5xFAD mice were smaller in size,had rough and sparse fur,and showed a decreased weight gain.The percentage of time spent entering the novel arm and the percentage of time spent exploring the newly replaced object side in the novel object recognition test stage were significantly decreased(all P<0.05),and the time required for the mice to find the target area in the maze during the test period was prolonged(P<0.05).The expression level of Aβ protein and the number of microglia were significantly increased(all P<0.05),while the fluorescence intensity of LXR in the mouse brain and the expression of PSD95 and SYN-1 were decreased(all P<0.05).Compared with the 5xFAD group,5xFAD-MD group mice were larger in size,had thick fur,and gained weight.The percentage of time spent entering the novel arm, the number if ontvies into the novel arm,and the percentage of time spent exploring the newly replaced object side in the novel object recognition test stage,all increused(all P<0.05).The time required for the mice to find the target area in the maze during the test period,was shortened(all P<0.05).The expression level of Aβ protein and the number of microglia significantly decreased(all P<0.05),while the fluorescence intensity of LXR in the mouse brain and the expression of PSD95 and SYN-1 were increased(all P<0.05).Conclusion:MD exerts cognitive protect effects in 5xFAD mice by ameliorating synaptic function and suppressing neuroinflammation,potentially via activation of LXR receptors and inhibition of microglial activation.

参考文献/References:

[1]WANG D,CHEN F,HAN Z,et al.Relationship between amyloid-β deposition and blood-brain barrier dysfunction in Alzheimer’s disease[J].Frontiers in Cellular Neuroscience,2021,15:695479.
[2]SCHELTENS P,DE STROOPER B,KIVIPELTO M,et al.Alzheimer’s disease[J].The Lancet,2021,397(10284):1577-1590.
[3]王坤,张宸豪,荣萌萌,等.阿尔茨海默病患者血清三磷酸腺苷结合盒转运蛋白7、基质金属蛋白酶9、脂联素水平与认知功能相关性分析[J].陕西医学杂志,2024,53(10):1387-1390.
[4]WANG J,GU B J,MASTERS C L,et al.A systemic view of Alzheimer disease-insights from amyloid-β metabolism beyond the brain[J].Nature Reviews Neurology,2017,13(10):612-623.
[5]DIB S,LOIOLA R A,SEVIN E,et al.TNFα activates the liver X receptor signaling pathway and promotes cholesterol efflux from human brain pericytes independently of ABCA1[J].International Journal of Molecular Sciences,2023,24(6):5992.
[6]ALBILLOS A,DE GOTTARDI A,RESCIGNO M.The gut-liver axis in liver disease:Pathophysiological basis for therapy[J].Journal of Hepatology,2020,72(3):558-577.
[7]SHIPPY D C,ULLAND T K.Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation[J].Scientific Reports,2023,13(1):14800.
[8]WEISS F,HUGHES L,FU Y,et al.Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model[J].Translational Neurodegeneration,2024,13(1):1-21.
[9]ZELCER N,KHANLOU N,CLARE R,et al.Attenuation of neuroinflammation and Alzheimer’s disease pathology by liver x receptors[J].Proceedings of the National Academy of Sciences,2007,104(25):10601-10606.
[10]ZHOU E,GE X,NAKASHIMA H,et al.Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation[J].EMBO Molecular Medicine,2023,15(8):e16845.
[11]BALLARINI T,MELO VAN LENT D,BRUNNER J,et al.Mediterranean diet,Alzheimer disease biomarkers,and brain atrophy in old age[J].Neurology,2021,96(24):e2920-e2932.
[12]ZHANG M,QIAN C,ZHENG Z G,et al.Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer’s disease through activating Axl/HSP90/PPARγ pathway[J].Theranostics,2018,8(15):4262-4278.
[13]ZHAN N,WANG B,MARTENS N,et al.Identification of side chain oxidized sterols as novel liver X receptor agonists with therapeutic potential in the treatment of cardiovascular and neurodegenerative diseases[J].International Journal of Molecular Sciences,2023,24(2):1290.
[14]YOSHIKAWA T,SHIMANO H,YAHAGI N,et al.Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor(LXR) binding to LXR response elements[J].Journal of Biological Chemistry,2002,277(3):1705-1711.
[15]ZHAI S,YIN M M,SUN H Q,et al.The day-night differences in cognitive and anxiety-like behaviors of mice after chronic sleep restriction[J].The FASEB Journal,2023,37(7):e23034.
[16]LUEPTOW L M.Novel object recognition test for the investigation of learning and memory in mice[J].Journal of Visualized Experiments:JOVE,2017(126):55718.
[17]ATTAR A,LIU T,CHAN W T C,et al.A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer’s disease[J].PLoS One,2013,8(11):e80355.
[18]OBLAK A L,LIN P B,KOTREDES K P,et al.Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications:A Model-AD study[J].Frontiers in Aging Neuroscience,2021,13:713726.
[19]WINKLER I,TOLKACHOV A,LAMMERS F,et al.The cycling and aging mouse female reproductive tract at single-cell resolution[J].Cell,2024,187(4):981-998.
[20]LI J G,MUTREJA Y,SERVILI M,et al.The anti-neuroinflammatory effect of extra-virgin olive oil in the triple transgenic mouse model of Alzheimer’s disease[J].Journal of Alzheimer’s Disease,2024,100(1):119-126.
[21]SEHAR U,RAWAT P,REDDY A P,et al.Amyloid beta in aging and Alzheimer’s disease[J].International Journal of Molecular Sciences,2022,23(21):12924.
[22]WEN J,SATYANARAYANAN S K,LI A,et al.Unraveling the impact of Omega-3 polyunsaturated fatty acids on blood-brain barrier(BBB) integrity and glymphatic function[J].Brain,Behavior,and Immunity,2024,115:335-355.
[23]METT J.The impact of medium chain and polyunsaturated ω-3-Fatty acids on amyloid-β deposition,oxidative stress and metabolic dysfunction associated with Alzheimer’s disease[J].Antioxidants,2021,10(12):1991.
[24]王登坤,第五永长,苟于瑞,等.基于糖脂代谢探讨肠道微生物组与阿尔茨海默病的关系[J].陕西医学杂志,2025,54(4):565-570.
[25]LEWANDOWSKI C T,LAHAM M S,THATCHER G R J.Remembering your A,B,C’s:Alzheimer’s disease and ABCA1[J].Acta Pharmaceutica Sinica B,2022,12(3):995-1018.
[26]KHOURY Z S,SOHAIL F,WANG J,et al.Neuroinflammation:A critical factor in neurodegenerative disorders[J].Cureus,2024,16(6):e62310.
[27]LITVINCHUK A,SUH J H,GUO J L,et al.Amelioration of tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist[J].Neuron,2024,112(3):384-403.
[28]PRADA I,GABRIELLI M,JOSHI P,et al.Role of extracellular vesicles in early synaptic dysfunction in AD[J].Alzheimer’s & Dementia,2022,18(S4):e065992.
[29]CAI W,LI L,SANG S,et al.Physiological roles of β-amyloid in regulating synaptic function:Implications for AD pathophysiology[J].Neuroscience Bulletin,2023,39(8):1289-1308.
[30]CANSEV M,TURKYILMAZ M,SIJBEN J W C,et al.Synaptic membrane synthesis in rats depends on dietary sufficiency of vitamin C,vitamin E,and selenium:Relevance for Alzheimer’s disease[J].Journal of Alzheimer’s Disease,2017,59(1):301-311.

相似文献/References:

[1]邓春颖,李海滨,毛文静,等.丁苯酞对阿尔茨海默病模型大鼠海马CA1 区脑源性神经营养因子和碱性成纤维生长因子蛋白表达影响的实验研究*[J].陕西医学杂志,2020,49(4):405.
 DENG Chunying,LI Haibin,MAO Wenjing,et al.Effect of dl-3-n-butylphthalide on the expression of BDNF and bFGF in CA1 region of hippocampus of Alzheimer disease rats[J].,2020,49(7):405.
[2]程 艳,郭建伟,李 扬,等.超氧化物歧化酶融合蛋白改善阿尔茨海默病小鼠大脑白质超微结构实验研究[J].陕西医学杂志,2022,51(9):1049.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.002]
 CHENG Yan,GUO Jianwei,LI Yang,et al.Experimental study of superoxide dismutase fusion protein improving ultrastructure of cerebral white matter in mice with Alzheimer's disease[J].,2022,51(7):1049.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.002]
[3]王 坤,张宸豪,荣萌萌,等.阿尔茨海默病患者血清三磷酸腺苷结合盒转运蛋白7、基质金属蛋白酶9、脂联素水平与认知功能相关性分析[J].陕西医学杂志,2024,(10):1387.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.019]
 WANG Kun,ZHANG Chenhao,RONG Mengmeng,et al.Correlation between serum ABCA7,MMP-9,ADPN levels and cognitive function in patients with Alzheimer's disease[J].,2024,(7):1387.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.019]
[4]王登坤,第五永长,苟于瑞,等.基于糖脂代谢探讨肠道微生物组与阿尔茨海默病的关系[J].陕西医学杂志,2025,54(4):565.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.026]
 WANG Dengkun,DI WU Yongchang,GOU Yurui,et al.Discussing the link between gut microbiome and Alzheimer's disease based on glucose and lipid metabolism[J].,2025,54(7):565.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.026]
[5]武文玉,李俊霞,韩广卉,等.不同饮食模式对炎症性肠病的影响研究进展[J].陕西医学杂志,2025,54(12):1717.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.023]
 WU Wenyu,LI Junxia,HAN Guanghui,et al.Research Progress on effects of different dietary patterns on inflammatory bowel disease[J].,2025,54(7):1717.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.023]
[6]于彤,张润宁,杜婴.蛋白激酶C δ在阿尔茨海默病病理损害中的作用及机制研究进展[J].陕西医学杂志,2026,(4):566.[doi:DOI:10.3969/j.issn.1000-7377.2026.04.024]
 YU Tong,ZHANG Running,DU Ying.Advances in the role and mechanisms of PKCδ in pathological damage of Alzheimer’s disease[J].,2026,(7):566.[doi:DOI:10.3969/j.issn.1000-7377.2026.04.024]

备注/Memo

备注/Memo:
国家自然科学基金资助项目(81772454,81971237);江苏省科技局科研项目(BE2017734);江苏省重点研发计划重点项目(BE2023023-2)
更新日期/Last Update: 2025-07-07